Meet-the-Expert |
Education Session |
EHA / ESH Joint Symposium |
Lunch Debates |
Opening Ceremony |
Molecular Hemopoiesis Workshop |
Poster Session I
LUNCH DEBATE
11.30 - 12.30 hours, Room: Mozart I
IS THERE A ROLE FOR ALLOGENEIC TRANSPLANTATION
IN MULTIPLE MYELOMA?
Chair: G. Gahrton (Karolinska Institute, Stockholm, Sweden)
- YES
N. Kröger (University Medical Center Hamburg, Hamburg, Germany)
- NO
P. Moreau (University Hospital, Nantes, France)
LUNCH DEBATE
11.30 - 12.30 hours, Room: Mozart II
ALL ELIGIBLE PATIENTS RESISTANT TO IMATINIB
SHOULD BE OFFERED A TRANSPLANT?
Chair: B. Simonsson (Uppsala University, Uppsala, Sweden)
- YES
A. Gratwohl (University Hospital Basel, Basel, Switzerland)
- NO
H. Kantarijan (MD Anderson Cancer Centre, Houston, USA)
LUNCH DEBATE
11.30 - 12.30 hours, Room: Mozart III
SHOULD PARENTERAL IRON BE ADMINISTERED CONCOMITANTLY
WITH ERYTHROPOIETIC AGENTS FOR TREATMENT OF ANEMIA IN
CANCER PATIENTS?
Chair: P. Beris (Geneva University Hospital, Geneva, Switzerland)
- YES
G. Birgegard (Uppsala University, Uppsala, Sweden)
- NO
Y. Beguin (University of Liege, Liege, Belgium)
